1. Overview

Harvard Office Practice of Primary Care Medicine 2026 Harvard Office Practice of Primary Care Medicine 2026 The Harvard Office Practice of Primary Care Medicine 2026 course provides a comprehensive update on a wide range of topics essential for daily primary care practice. The program covers the latest evidence-based guidelines and management strategies for common acute and chronic conditions, preventive medicine, behavioral health, and specialized care considerations.

Course Date: March 16 – 20, 2026

2. Learning Objectives

3. Target Audience

Best for primary care physicians, nurse practitioners, and physician assistants who want updates on chronic disease management and preventive care.

4. Topics

1. 01 Headaches Angeliki Vgontzas

2. 02 Hypertension Aaron Mann

3. 03 Antibiotics in Office Practice Jacob Johnson

4. 04 Respiratory Infections Paul Sax

5. 05 Coronary Artery Disease Aeron Small

6. 06 Hyperlipidemia Scott Kinlay

7. 07 Diabetes Update Marie McDonnell

8. 08 A1 – Challenging Diabetes Cases – Marie McDonnell

9. 09 A2 – Pelvic Floor Disorders – Milena Weinstein

10. 10 A3 – Hip Pain – Michael Beasley

11. 11 A4 – Gynecology Cases in Primary Care – Bevin Kenney

12. 12 B1 – Cardiac Imaging Cases – Diana Lopez

13. 13 B2 – Neuropathic Pain Treatment – Paragi Rana

14. 14 B3 – Motivational Interviewing – Joji Suzuki

15. 15 B4 – Geriatric Cases – Julia Loewenthal

16. 16 Dementia Andrew Budson

17. 17 Resistant Hypertension Naomi Fisher

18. 18 Colon Cancer Screening Robert Lowe

19. 19 Breast Cancer Screening Lydia Pace

20. 20 Hematologic Cases Robert Stern

21. 21 Top Primary Care Articles Eve Rittenberg

22. 22 C1 – Thyroid Cases – Sara Ahmadi

23. 23 C2 – Pre-Operative Cardiac & Pulmonary Consultation – Adam Schaffer

24. 24 C3 – Anxiety – Joe Tulip

25. 25 C4 – Climate Change and Human Health – Gregg Furie

26. 26 D1 – Lyme Disease and Other Tick-Borne Illnesses – Daniel Solomon

27. 27 D2 – Artificial Intelligence in Primary Care – David Bates

28. 28 D3 – Knee Pain – Elizabeth Matzkin

29. 29 D4 – Food and Drug Allergies – David Sloane

30. 30 E1 – Billing Tips for PCPs – Stuart Pollack

31. 31 E2 – Science and Practice of Healthy Eating – Katherine McManus, MS, RD, LDN

32. 32 E3 – Electrolyte Cases – Brad Denker

33. 33 E4 – Care for Unhoused Patients – Jennifer Brody

34. 34 Acute Dizziness and Vertigo Kevin Kerber

35. 35 Atrial Fibrillation Paul Zei

36. 36 Heart Failure Cases Akshay Desai

37. 37 Managing MASLD, Acute Hepatitis, and Compensated Cirrhosis Anna Rutherford

38. 38 Pharmacologic Management of Depression David Kroll

39. 39 Asthma Nancy Lange-Vaidya

40. 40 Medical Treatment for Obesity Chioma Tomlinson, PA-C

41. 41 F1 – Hand and Elbow Problems – Simon Talbot

42. 42 F2 – Approach to Peripheral Neuropathy – Michael Bowley

43. 43 F3 – Bipolar Disease and ADHD – Rachel Rosales

44. 44 F4 – Buprenorphine 101 – Alev Atalay

45. 45 G1 – Urology Cases – Martin Kathrins

46. 46 G2 – PrEP and HIV – Ellen Nagami

47. 47 G3 – Ophthalmology – Mina Farahani

48. 48 G4 – Stroke Cases – Mariel Kozberg

49. 49 COPD Craig Hersh

50. 50 Cervical Cancer Screening Cristina Alexander

51. 51 Adult Immunization Updates Daniel Solomon

52. 52 Low Back Pain Dana Kotler

53. 53 CKD Management John Kevin Tucker

54. 54 Can’t-Miss Primary Care Cases Maria Yialamas

55. 55 H1 – Irritable Bowel Syndrome – Molly Perencevich

56. 56 H2 – Pharmacologic Treatment of Alcohol Use Disorder – Salah Alrakawi

57. 57 H3 – Primary Care for Transgender and Gender Diverse Patients – Ole-Petter Hamnvik

58. 58 H4 – Contraception – Kathryn Fay

59. 59 I1 – Shoulder Pain – George Dyer

60. 60 I2 – UTIs – Jacob Lazarus

61. 61 I3 – Office ENT Problems – Dunia Abdul-Aziz & Alan Workman

62. 62 I4 – End-of-Life Discussions and Advanced Care Directives – Allyson Goldberg

63. 63 J1 – STIs – Jana Jarolimova

64. 64 J2 – Sleep Apnea – Rohit Budhiraja

65. 65 J3 – Rheumatology Cases – Candace Feldman

66. 66 J4 – Care of Patients with Intellectual Disabilities – Frances (Kitty) O’Hare

67. 67 Prostate Cancer Screening and Beyond Marc Garnick

68. 68 Lung Cancer Screening Samuel Ash

69. 69 Insomnia Treatment Suzanne Bertisch

70. 70 Menopause Management Kathryn Corelli

71. 71 Osteoporosis Sharon Chou

72. 72 GERD and Peptic Ulcer Disease Navin Kumar

73. 73 Dermatology Updates Sotonye Imadojemu

74. 74 K1 – Tobacco, Vaping, and E-Cigarette Cessation – Nancy Rigotti

75. 75 K2 – Advanced Dermatology Cases – Alexandra Charrow

76. 76 K3 – Foot and Ankle Pain – Jeremy Smith

77. 77 K4 – Chronic Pain Management with Opioids – James Morrill

78. 78 L1 – Lifestyle Medicine for Patients & Their Clinicians – Elizabeth Frates

79. 79 L2 – Outpatient Approach to DVT and PE – Gregory Piazza

80. 80 L3 – Travel Medicine – Carolina Geadas

81. 81 L4 – Adolescent Medicine Cases – Joshua Borus

🫀 Mayo Clinic Adult Congenital Heart Disease Board Review 2025 (ACHD)

Prepare for the ABIM Adult Congenital Heart Disease (ACHD) board exam with the
Mayo Clinic 2025 Online Board Review, a comprehensive CME program featuring
personalized adaptive learning, expert lectures, and full curriculum coverage.

This course includes pre- and post-assessments, allowing you to identify knowledge gaps and focus on areas that need improvement through a structured, board-focused learning pathway.

✔ 18 Months Access | CME + MOC Eligible | Board-Focused

📦 Course Features

• Online streaming access (18 months)
• Pre-test & post-test assessments
• Personalized adaptive learning system
• Video lectures + audio + downloadable PDFs
• Board key points, guidelines & references

🎯 Learning Objectives

• Differentiate simple vs complex congenital heart lesions
• Select and interpret appropriate diagnostic tests
• Determine optimal timing for surgical intervention
• Develop evidence-based management strategies
• Risk stratify patients for sudden cardiac death

🧠 Full Curriculum Overview

🧠 Foundations & Diagnostics

• Genetics & inherited syndromes
• Cardiac anatomy & embryology
• Cardiac catheterization & shunt assessment
• Advanced imaging (Cardiac MRI & CT)
• Physical exam clinical pearls

🫀 Congenital Heart Lesions

• ASD, VSD & AV Canal defects
• Tetralogy of Fallot (TOF)
• Transposition of the Great Arteries (TGA)
• Eisenmenger Syndrome
• Single ventricle & Fontan physiology

🧬 Vascular & Outflow Disorders

• Aortopathy (BAV, Turner syndrome)
• Vascular rings & anomalies
• LVOT obstruction & coarctation

🏥 Advanced Clinical Management

• Heart failure (HF) & advanced therapies
• Pulmonary hypertension (PH)
• Congenital cardiac surgery & risk assessment

👩‍⚕️ Reproductive & Systemic Considerations

• Pregnancy risk (mWHO, CARPREG II)
• Contraception in CHD patients
• Extracardiac complications (brain, lungs, liver)

👨‍⚕️ Target Audience

• Cardiologists
• Internal Medicine Physicians
• Fellows & Residents
• Nurse Practitioners & Physician Assistants
• Healthcare professionals managing ACHD patients

⭐ Why Choose This Course?

• From Mayo Clinic (world-leading institution)
• Aligned with ABIM ACHD exam blueprint
• Personalized adaptive learning system
• Comprehensive and structured curriculum
• Latest updates in congenital cardiology (2025)

1. Overview

The Congenital Cardiac Anesthesia Society (CCAS) Annual Meeting is a premier medical conference dedicated to advancements in pediatric cardiac anesthesia and the perioperative care of patients with congenital heart disease. Held on March 12, 2026, the event covers a wide spectrum of contemporary topics, from digital frontiers like machine learning and 3D modeling to novel therapeutics, pediatric heart transplantation, and the evolving challenges of managing aging congenital heart disease patients.

2. Learning Objectives

• Understand the applications and ethical considerations of artificial intelligence, machine learning, and 3D virtual planning in congenital heart disease management.

• Evaluate novel pharmacological therapeutics, including myosin inhibitors, remimazolam, and SGLT2 inhibitors, in the perioperative care of congenital cardiac patients.

• Discuss advancements and current challenges in pediatric heart transplantation, xenotransplantation, and heart preservation techniques.

• Analyze complex perioperative management scenarios, such as coagulation in pediatric bypass, the economics of heart centers, and the anesthetic implications for aging patients with congenital heart disease.

3. Target Audience

Best for pediatric anesthesiologists who want key updates on congenital heart disease care, novel therapeutics, and AI applications.

4. Topics:

1. Machine Learning and Predictive Modeling in the Diagnosis and Management of Congenital Heart Disease

2. Ethical Considerations for AI Use in CHD Management – Anesthetic Implications

3. 3D Modeling and Virtual Planning in Congenital Cardiac Surgery

4. Myosin Inhibition in Hypertrophic Cardiomyopathy – Perioperative Considerations

5. Next-Generation Pediatric Cardiac Catheterization – What the Anesthesiologist Should Know

6. New Frontiers in Coagulation Management – Pediatric Bypass in SCD and HIT

7. Challenges in Pediatric Heart Allocation

8. Advances in Pediatric Heart Preservation

9. Dolly D. Hansen, MD Lecture – Pediatric Cardiac Xenotransplantation

10. Who Should Provide Care for Fontan Patients. CV vs. General Pediatric Anesthesiologists General Peds Anesthesia

11. Who Should Provide Care for Fontan Patients. CV vs. General Pediatric Anesthesiologists CV Anesthesia

12. Heart Center Economics – Hospital vs. Anesthesiologist Viewpoints

13. Dolly D. Hansen, MD Research Award Update

14. Remimazolam in Pediatric Cardiac Anesthesia – A Novel Sedative with Promise

15. Congenital Heart Disease Beyond Midlife – Anesthetic Implications for the Aging Patient

16. SGLT2 Inhibitors in CHD Patients – Perioperative Implications

17. March 12, 2026 (Full Day Recording)

18. SESSION I Digital Frontiers in CHD – Innovation and Technological Advances

19. SESSION II Novel Therapeutics in Congenital Cardiac Care – Bridging Innovation and Clinical Practice

20. SESSION III Focus on a Lesion – Pediatric Heart Transplantation – Redefining the Limits of the Donor Pool

21. SESSION IV Poll of the Month Hot Topics

22. SESSION V Best Posters, Research & Awards

23. SESSION VII Important Papers of the Year – Novel Topics in Congenital Cardiac Anesthesia

1. Overview

The American Heart Association International Stroke Conference OnDemand 2026 provides a comprehensive, global update on the latest advancements in stroke care, cerebrovascular disease, and brain health. The program features late-breaking science, high-profile clinical trial updates, and multidisciplinary discussions ranging from acute prehospital management and neurointervention to advanced rehabilitation and the integration of artificial intelligence in stroke systems.

Course Date: 2026

2. Learning Objectives

• Evaluate late-breaking science and high-profile clinical trials to inform evidence-based stroke prevention, acute management, and reperfusion strategies.

• Analyze advancements in neurointervention, minimally invasive surgeries, and mechanical thrombectomy for complex cerebrovascular conditions.

• Assess the impact of emerging technologies, including artificial intelligence, virtual reality, and polygenic risk scores, on precision stroke diagnosis and care.

• Implement multidisciplinary models of care for diverse populations, addressing global health disparities, pediatric stroke, and rural stroke management challenges.

• Formulate comprehensive post-stroke recovery plans that incorporate regenerative medicine, psychosocial support, and targeted rehabilitation therapies.

3. Target Audience

Best for neurologists, neurosurgeons, and emergency medicine physicians who want updates on stroke management, neurointervention, and clinical trials.

4. Topics

1. A Child Shows Up In An Adult Emergency Room To Reperfuse or Not to Reperfuse That is the Question Debate

2. A Conversation with the Journal Editors Fireside Chat

3. Acute Ischemic Stroke Guidelines QA Part I Interventional Treatments and Pediatrics Fireside Chat

4. Acute Ischemic Stroke Guidelines QA Part II Early Medical Management and Systems of Care and Prehospital Fireside Chat

5. Acute Ischemic Stroke Management Oral Abstracts I

6. Acute Ischemic Stroke Management Oral Abstracts II

7. Aging Immune System Implications for Cerebrovascular Disease and Brain Health

8. And the Children Shall Lead Them Advances in Pediatric Stroke Research for Adult Stroke Neurologists

9. Applied Neuroangiography What a Stroke Neurologist Needs to Know

10. Arteriosclerosis Thrombosis and Vascular Biology Oral Abstracts

11. Beyond City Limits State-of-the-Art Stroke Care in Prehospital and Rural Settings

12. Beyond the Plenary Deeper Dives into OCEANIC-STROKE CREST-2 and FASTEST Late-Breaking Science Oral Abstracts III

13. Brain Health and Cognitive Impairment Oral Abstracts

14. Brain Health in an Aging Population Behavioral Risk Reduction an Alzheimers Association American Stroke Association Joint Symposium

15. Brain-Kidney Interaction a Japan Stroke Society American Stroke Association Joint Symposium

16. Bridging Continents Building Equitable High-Impact Stroke Systems of Care an Indian Stroke Association American Stroke Association Joint Symposium

17. Bridging Gaps in Stroke Care A Middle East North Africa Stroke Organization American Stroke Association Joint Symposium

18. Cancer and Ischemic Stroke – an Underappreciated Etiology

19. Carotid Artery Disease in 2026 as Informed by Randomized Trials and Other Studies

20. Cerebrovascular Systems and Multidisciplinary Models of Care Oral Abstracts

21. Challenges in the Globalization of Stroke Care From Vision to Action a World Stroke Organization American Stroke Association Joint Symposium

22. Closing Main Event

23. Code ICH reorganizing care of ICH patients a Neurocritical Care Society American Stroke Association Joint Symposium

24. Complexities and Complications Lessons In Training Trainee Case Studies Session

25. Controversies on Minimally Invasive Surgeries in ICH Fireside Chat

26. Cytoprotection Novel Targets For Stroke Recovery European and American Perspectives a European Stroke Organisation American Stroke Association Joint Symposium

27. Embolic Stroke of Undetermined Source Contemporary Treatment Paradigms a JAHA Journal Session

28. Epidemiology Risk Factors and Prevention Oral Abstracts I

29. Epidemiology Risk Factors and Prevention Oral Abstracts II

30. Fine-tuning Mechanical Thrombectomy The Role of Medical Interventions a Stroke Journal session

31. Friday Main Event Late-Breaking Science Trials QA Fireside Chat

32. Frontiers in Neurointervention Expanding the Boundaries Beyond Large Vessel Occlusion and AneurysmAVM Embolization

33. GLP-1 Targeted Therapies for Cerebrovascular and Brain Health

34. Grey Areas Decision Making in Difficult Cases

35. Hard to Crack Comprehensive Strategies For Diagnosing and Treating Acute Large Vessel Occlusion due to Intracranial Atherosclerosis

36. Health Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts I

37. Health Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts II

38. Hemorrhagic Stroke Treatment Oral Abstracts

39. High Profile Clinical Trials 2026 Reperfusion Therapy

40. Hypertension Management and Stroke Prevention Successes and Future Challenges Response from The American Heart Association

41. Imaging in Stroke Oral Abstracts

42. Interpreting the AHAs Scientific Statements Presentations and QA Fireside Chat

43. Intracranial Atherosclerotic Disease Bench to Bedside

44. It Aint Only Stroke Vascular Contributions to Brain Disorders Other Than Stroke an American Academy of Neurology American Stroke Association Joint Symposium

45. Late-Breaking Science Oral Abstracts I

46. Late-Breaking Science Oral Abstracts II

47. Late-Breaking Science Oral Abstracts IV

48. Lessons from Neutral neuromodulation stroke motor recovery trials

49. Migraine and Stroke The Double-edged Sword an American Headache Society American Stroke Association Joint Symposium

50. Molecular and Cellular Brain Science Oral Abstracts

51. Moyamoya Revisited Advances in Pathophysiology and Treatment

52. Networks in Action Building Collaborative Models for Stroke Research and Care

53. Neurocognitive Sequela of Aneurysmal Subarachnoid Hemorrhage

54. Neuroimmunology and Inflammation in Stroke Oral Abstracts

55. Neurointervention Oral Abstracts

56. Next Generation Stroke Care in the World of AI a Korean Stroke Society American Stroke Association Joint Symposium

57. Novel Technologies in Neuro-Intervention a SVIN Journal Session

58. Omics Big Data Precision Medicine Bioengineering and Artificial Intelligence Oral Abstracts

59. Opening Main Event

60. Optimizing Cell Therapy for Stroke

61. Optimizing Stroke Care in Underserved Setting Challenges and Strategies for Rural and Safety-net Hospitals

62. Pediatric Stroke Oral Abstracts

63. Perfusion Imaging in Acute Stroke for EVT Eligibility Past Glory or Promise for the Future Debate

64. Polygenic Risk Scores in Stroke From Genomics to Precision Care

65. Post-Stroke Care Oral Abstracts

66. Post-Stroke Dysphagia New Evidence to Guide Evaluation and Management in the Acute Care Setting

67. Preclinical Stroke Research Networks A Critical Assessment of Progress and Potential

68. Prequel to the Closing Main Event Late-Breaking Science Trials QA Fireside Chat

69. Prevention and Treatment of Maternal Stroke in Pregnancy and Postpartum Scientific Statement by the American Heart Association

70. Priorities in Stroke Prevention Research Bridging Basic and Clinical Advances a National Institute of Neurological Disorders and Stroke

71. Recovery after Hemorrhagic Stroke Patient and Caregiver Experiences a Bugher Foundation Session

72. Red Blood Cells and Stroke Pathogenesis

73. Regenerative Medicine and Novel Therapeutic Strategies Oral Abstracts

74. Rehabilitation and Recovery Oral Abstracts

75. Silent Strokes Loud Consequences The true impact of covert brain infarct Debate

76. Spasticity Management in Post-Stroke Recovery Discussing Different Case Presentations

77. Stroke in 2026 Navigating Controversies in Ischemic Stroke Treatment Debate

78. Stroke in Asia Epidemiology Mechanisms and Hemorrhage an Asia Pacific Stroke Organization American Stroke Association Joint Symposium

79. Technology Friend or Foe an Australian and New Zealand Stroke Organisation American Stroke Association Joint Symposium

80. Technology-Enhanced Psychosocial Support for Stroke Recovery

81. The Paola De Rango Memorial Session Sex and Gender Differences Related to Cognitive Impairment and Dementia after Stroke

82. The Use of AR VR MR in the Spectrum of Stroke Care

83. Thursday Main Event Late-Breaking Science Trials QA Fireside Chat

84. Thursday Main Event

85. Tiny Threats The Small Aneurysm Controversies Fireside Chat

86. To HIIT or Not to HIIT That is Todays Question for Stroke Care Bench to Bedside

87. Train Advocate Measure Repeat Expanding Global Access to Thrombectomy

88. Translational Research Therapeutic Development and Biomarkers Oral Abstracts

89. Treatment Gaps and Cooperation Strategies in Stroke Care A USMexico Collaborative Summit a La Asociación Mexicana de Enf…

90. Unraveling the Molecular Underpinnings of Brain Injury After Ischemia and Hemorrhage

91. Vascular Malformations Aneurysms Moyamoya and Other Vascular Conditions Oral Abstracts

92. Whats New in the 2026 Acute Ischemic Stroke Guideline Process Overview and Key Updates from the Chairs

  4 videos + 53 pdf, size: 6.07 GB

+ Information:

Friday, January 23, 2026, 7:30 AM – Sunday, January 25, 2026, 2:55 PM PT, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA

Target Audience

A major national healthcare imperative for noninvasive imaging is for the tests to provide value. Nuclear cardiology and cardiac CT studies provide powerful tools for diagnosis, risk assessment, and guiding management of selected patients with known or suspected cardiac disease. In the current environment, imaging must address the combined considerations of improving outcomes and containing costs. To this end, advanced cardiac imaging studies must be ordered on the right patients and optimally performed, interpreted, reported, and acted upon by physicians and allied health professionals. Additionally, effective methods to reduce radiation exposure need to be implemented to maximize patient safety. There is a clear need for physicians ordering, performing and interpreting the tests to understand the issues regarding value-based imaging and to optimally implement this understanding. We meet these educational needs through a live activity entitled: Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 38th Annual Case Review with the Experts. The course is designed to meet the current needs of professionals who perform or request nuclear cardiology or cardiac CT. The course covers the use of these modalities across the spectrum of patients routinely seen by cardiologists in typical day-to-day practice and is designed to improve ordering patterns and increase quality in performing, interpreting, reporting and applying the advanced imaging methods. A unique feature of the program is the extensive use case presentations of each subject as a proven effective teaching tool. It also includes multiple sessions with group faculty discussions. There is a focus on incorporating new guidelines in practice and the latest evidence from clinical trials and registry findings

1. Identify up to date evidence regarding the information provided by tests, the appropriate use of testing an how the tests affect outcomes an costs in coronary and noncoronary heart and aortic disease
2. Recognize the implications of 2019 ESC CTA ACCAHA chest pain guidelines on the use of noninvasive testing
3. Implement the latest acquisition processing protocols, instrumentation and software for multiple imaging modalities
4. Explain how new approaches to functional assessmentsuch as coronary flow reserve, noninvasive fractional flow reserve, and plaque measurementsenhance the information obtained from testing.
5. Improve image interpretation and recognition of image artifacts
6. Recognize strategies tor educe patient radiation and contrast exposure while conduct high quality studies
7. Apply optimal protocols for pharmacologic stress testing
8. Create optimal reports that integrate test findings and provide guidance for patient management
9. Identify the latest information regarding how test findings should be used to guide patient management decision
10. Use criteria and evidence based strategies to reduce inappropriate testing
11. Identify knowledge gaps regarding blueprints for the CBNC and CBCCT Boards

Topics :

1. AI in Cardiac CTA- Quantification of Coronary Plaque- Prediction of Risk-Prediction, and Ischemia

2. Amyloid Quantitation- Decreasing Subjectivity in PYP Interpretation

3. Amyloid Specific PET Tracers

4. Beyond Perfusion with MPI- AI Analysis of CAC, Chamber Volumes, Epicardial Fat, Body Composition and Beyond

5. Beyond the Images- The Essential Role of Excercise and Functional Assessment in Cardiac Testing

6. Cardiac MRI and PET in Microvascular Disease

7. Cardiac MRI in Sarcoidosis and Other Inflammatory Cardiomyopathies

8. Case Review- CTA in Valvular Disease

9. Case-Based Interpretation of Flurpiridaz MPI

10. Central Role of Cardiac CT in Structural Heart Disease

11. Changing the Outlook in Cardiac Amyloidosis- Current and Novel Therapies

12. Choosing Between Flurpiridaz and Rubidium

13. Class IA Guideline Recommendation for Chest Pain- What Evidence Brought Coronary CTA Here

14. Clinical Value of Myocardial Blood Flow Measurement

15. Combining Anatomy and Physiology with SPECT and PET. Crucial Role of CAC Scanning in Patients

16. Coronary Artery Calcium (CAC) Scanning- Central Role in Preventive Cardiology

17. Coronary CT in Mitral Valve and Afib- Watchman and TMVR

18. Coronary CTA and FFRct for the Interventionalist- Use in Planning and Guiding PCI

19. Coronary CTA in Asymptomatic Patients

20. Coronary CTA in Evaluation of Patients with Known CAD (Stents, CABG)

21. Coronary CTA in Evaluation of Suspected CAD in Daily Practice

22. Coronary CTA- Special Consideration for Women

23. Debate- Coronary CTA Will Replace Stress Testing

24. Evolving Trends in CAD- Shifting Risk Factors, Symptoms, and Mortality Drivers

25. FDG PET in Sarcoidosis- Practical Considerations

26. Flurpiridaz- The Ideal PET Perfusion Tracer

27. Game-Show Jeopardy- Cardiac CT, Nuclear, and CMR

28. How to Integrate Stress Myocardial Blood Flow and Flow Reserve in Clinical Reporting and Guiding Therapy

29. How to Start Using Flurpiridaz- Lab Preparation, Protocols, Exercise vs Pharmacologic Stress

30. Incorporating Artificial Intelligence in Interpreting Reports of SPECT MPI- Case Interpretations

31. Integrating Visual and Quantitative Analyses of SPECT and PET- Improving Your Scan Interpretation- Case Illustrations

32. Ischeia Evaluation with Coronary CTA- FFRct

33. MBF-MFR with Cardiac MRI- Becoming Routine in Stress MRI

34. MBF-MFR with PET- How to Perform Quality Control, Interpret and Report

35. MFR with SPECT- Ready for Prime Time-

36. MRI in Cardiac Amyloidosis- Strengths and Limitations

37. My Best Teaching Cases

38. Myocardial Bridging and Coronary Anomalies on Coronary CTA- When is Further Assessement Needed and What Should It Be

39. Myocardial Viability- CMR and FDG PET

40. Nuclear Cardiology in 2026 and Beyond

41. Perfusion and Blood Flow Quantitation- Transmural and Subendocardial

42. PET or SPECT- Right Test for the Right Patient

43. Pharmacologic Stress- Combined with Exercise or Alone- What You Need to Know

44. Plaque Imaging in Guiding Patient Management

45. Problems fo Coronary CTA- Small Stents, CAC, Breathing

46. Putting it All Together- Value-Based Use of Cardiac Imaging

47. Quantitation in Sarcoidosis Interpretation

48. Quantitative Plaque Analysis in Tracking Progression of Disease

49. Stress First SPECT Protocols- Improved Defect Detection, Stress Only Procedures

50. Tc-99m Pyrophosphate (PYP) Imaging- Acquisition, Processing, Interpretation PET-based Radiotracers

51. The Disease, the Suspicion-Diagnostic Pathways, and Treatments

52. The Future of Cardiac CT- Photon Counting CT and More

 20 videos + 20 audios + 20 file sub vtt, size: 5.57 GB

+ Information:

1. Overview

The Southwest Florida Cardiovascular Imaging Symposium 2024 provides a comprehensive clinical update on the latest advancements and practical applications in cardiovascular imaging. The program focuses heavily on the growing capabilities of cardiac CT, the integration of artificial intelligence, and the use of advanced imaging biomarkers for risk assessment and structural heart interventions.

Course Date: 2024

2. Learning Objectives

• Evaluate the expanding diagnostic capabilities of cardiac CT in the evaluation of arrhythmias, cardiomyopathies, and aortic stenosis.

• Implement strategies to build and develop efficient cardiac CT programs and service lines within clinical practice.

• Apply advanced imaging biomarkers, such as CT-derived plaque, pericoronary fat, and epicardial fat, to accurately assess cardiovascular risk.

• Assess the role of CT, MRI, and PET imaging in the evaluation of cardiac masses and lesion-level ischemia.

• Utilize advanced imaging techniques, including CT-guided 3D printing and pre-procedural planning, to optimize outcomes in structural heart interventions and LAA occlusion.

3. Target Audience

Best for cardiologists and radiologists who want advanced updates on cardiac CT applications, structural heart imaging, and imaging biomarkers.

4. Topics

1. 01 Building Efficient Cardiac CT Programs – Panel Discussion

2. 02 Developing a Cardiac CT Service Line

3. 03 CT on Rhythm- Cardiac CT in Modern Evaluation of Arrhythmias

4. 04 Diagnostic Capabilities of Cardiac CT in Cardiomyopathies

5. 05 CT-Guided 3D Printing for Structural Heart Intervention

6. 06 Cardiac Masses – What is the role of CT, CMR and PET

7. 07 Harnessing Advanced Imaging Biomarkers – CT-derived Plaque and Pericoronary Fat

8. 08 Cardiac CT in Guiding Surgical Interventions- Case Studies and Innovations

9. 09 CT for Aortic Stenosis

10. 10 CT Derived Lesion Level Ischemia

11. 11 Cardiac MRI on the Heels of a CT Boom

12. 12 AI in CT

13. 13 Coronary CTA for Chronic Total Occlusion PCI

14. 14 Role of CAC and CCTA in Assessing Cardiovascular Risk- Current Trends and Future Directions

15. 15 The Role of CCTA in LAA Exclusion

16. 16 The Argument for Trans-esophageal Echocardiography in LAA Occlusion

17. 17 Perfusion, Functional CT and Future Advances of Cardiac CT

18. 18 Evolving Role of Cardiac CT in Women’s Coronary Disease

19. 19 Epicardial Fat – A Novel Marker of Cardiovascular Risk

20. 20 Peri-procedural LAAO Evaluation – Ditch the Probe